Various Radiopharmaceuticals

The Medical Readiness Contracting Office-West plans to award a Firm-Fixed-Price sole source call order to RLS Inc. for FDA-approved Radiopharmaceuticals, covering products such as I-131 and Table 1 products (Illucix, Netspot, Locametz, Detectnet). The performance period is set from October 1, 2025, to September 30, 2026, with an anticipated award date of September 15, 2025. This contract falls under the authority of 10 U.S. Code 3204(a)(1) and Federal Acquisition Regulation 6.302-1, which allows for a sole source contract when only one responsible source can meet agency requirements. The relevant NAICS code is 325412 – Pharmaceutical Preparation Manufacturing, with a size standard of 1,300 employees. The notice indicates that there will be no competitive proposals solicited, and the government reserves full discretion regarding the decision not to seek competition. Therefore, inquiries or requests for capability briefings related to this contract are not accepted, underscoring that this is a straightforward intent to contract with RLS Inc.